Technology ID
TAB-3290
Edema Factor Adenylate Cyclase Variants Having Potencies That Are Highly Dependent On the N-end Rule
E-Numbers
E-737-2013-0
Lead Inventor
Leppla, Stephen (NIAID)
Co-Inventors
Leysath, Clinton (The Texas A&M University System)
Applications
Research Materials
Therapeutic Areas
Infectious Disease
Lead IC
NIAID
ICs
NIAID
B. anthracis strains BH480; plasmids encoding anthrax edema factor (EF) variants pSJ136EFOS, pSJ 136EFA and pSJ 136EFR.
Commercial Applications
- A research material that can be used in the development of assays, validation of products or in quality control.
Competitive Advantages
- Speed up product development with NIH developed material that has already been tested and validated.
Licensing Contact: